Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Mercia Pharma Inc.
DescriptionFragment of amyloid protein conjugated to an immunogenic carrier and formulated with MAS-1 adjuvant
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPreclinical
Standard IndicationAlzheimer's disease (AD)
Indication DetailsTreat Alzheimer's disease (AD)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today